2.21
0.45%
+0.010
After Hours:
2.22
0.01
+0.45%
Inspira Technologies Oxy B.H.N. Ltd stock is currently priced at $2.21, with a 24-hour trading volume of 110.81K.
It has seen a +0.45% increased in the last 24 hours and a +15.71% rose in the past month.
The chart indicates a potential bearish trend, as the stock is below the $2.22 pivot point. If it approaches the $2.08 support level, significant changes may occur.
Previous Close:
$2.20
Open:
$2.18
24h Volume:
110.81K
Market Cap:
$38.22M
Revenue:
-
Net Income/Loss:
$-12.66M
P/E Ratio:
-2.0058
EPS:
-1.1018
Net Cash Flow:
-
1W Performance:
+17.55%
1M Performance:
+15.71%
6M Performance:
+78.23%
1Y Performance:
+68.70%
Inspira Technologies Oxy B.H.N. Ltd Stock (IINN) Company Profile
Name
Inspira Technologies Oxy B.H.N. Ltd
Sector
Industry
Phone
972 9 966 4488
Address
2 Ha-Tidhar Street, Raanana
Inspira Technologies Oxy B.H.N. Ltd Stock (IINN) Latest News
Inspira Technologies (IINN) Strives to Get AMAR Nod for ART100
Zacks Investment Research
Inspira Technologies (IINN) Releases Favorable Data on VORTX
Zacks Investment Research
Why Sony Shares Are Trading Lower By Around 6%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga
Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga
Why Ascent Industries Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket
Benzinga
Nasdaq Surges 75 Points; Inspira Technologies Shares Spike Higher
Benzinga
Inspira Technologies Oxy B.H.N. Ltd Stock (IINN) Financials Data
Inspira Technologies Oxy B.H.N. Ltd (IINN) Net Income 2024
IINN net income (TTM) was -$12.65 million for the quarter ending June 30, 2023, a -4.26% decrease year-over-year.
Inspira Technologies Oxy B.H.N. Ltd (IINN) Earnings per Share 2024
IINN earnings per share (TTM) was -$1.1018 for the quarter ending June 30, 2023, a +1.63% growth year-over-year.
About Inspira Technologies Oxy B.H.N. Ltd
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. The company was incorporated in 2018 and is based in Ra'annana, Israel.
Cap:
|
Volume (24h):